Indeed - in recent interviews SI stated that MSB wants to partner with other companies regarding back pain and heart failure treatments. The world market for these two 'blockbusters' is just too large to not involve established pharma.
I'm ok with that: major partners = increased manufacturing scale = lower unit cost = more patients successfully treated/greater revenue.
MSB Price at posting:
$4.89 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)